Importance of MEK-1/-2 signaling in monocytic and granulocytic differentiation of myeloid cell lines. Read more about Importance of MEK-1/-2 signaling in monocytic and granulocytic differentiation of myeloid cell lines.
Molecular characterization of genomic AML1-ETO fusions in childhood leukemia. Read more about Molecular characterization of genomic AML1-ETO fusions in childhood leukemia.
Programmed cell death regulation: basic mechanisms and therapeutic opportunities. Read more about Programmed cell death regulation: basic mechanisms and therapeutic opportunities.
IL-3 withdrawal activates a CrmA-insensitive poly(ADP-ribose) polymerase cleavage enzyme in factor-dependent myeloid progenitor cells. Read more about IL-3 withdrawal activates a CrmA-insensitive poly(ADP-ribose) polymerase cleavage enzyme in factor-dependent myeloid progenitor cells.
Inhibition of caspase proteases by CrmA enhances the resistance of human leukemic cells to multiple chemotherapeutic agents. Read more about Inhibition of caspase proteases by CrmA enhances the resistance of human leukemic cells to multiple chemotherapeutic agents.
A functional screen for regulators of the c-Abl protein tyrosine kinase. Read more about A functional screen for regulators of the c-Abl protein tyrosine kinase.
A randomized trial of high- vs standard-dose mitoxantrone with cytarabine in elderly patients with acute myeloid leukemia. Read more about A randomized trial of high- vs standard-dose mitoxantrone with cytarabine in elderly patients with acute myeloid leukemia.
Post-remission cytopenias following intense induction chemotherapy for acute myeloid leukemia. Read more about Post-remission cytopenias following intense induction chemotherapy for acute myeloid leukemia.
N-RAS gene activation in acute myeloid leukemia: association with expression of interleukin-6. Read more about N-RAS gene activation in acute myeloid leukemia: association with expression of interleukin-6.
